Abstract
Breast cancer appears to develop as a result of clones of cells accumulating a series of mutations. To model this process, we [1–9] and others [10–13] have introduced tumor mutations into individual clones of cells in mouse mammary epithelium, in mice, by a transplantation approach known as tissue reconstitution or constructing a transgenic mammary gland. Introducing oncogenes and growth factor genes in this way has shown how the three-dimensional growth pattern of mammary epithelium is altered by such genes and allows us to address basic questions, such as: What does an individual oncogene do to three-dimensional growth control? Do related oncogenes have similar or different effects? How do the effects of oncogenes relate to their normal role in controlling the three-dimensional growth pattern? How do clones of cells that express an oncogene behave among neighboring normal cells in an epithelium? The method also allows sequential introduction of more than one oncogene to follow tumor development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abram CL, Bradbury JM, Page MJ, Edwards PAW (1995) v-erbB induces abnormal patterns of growth in mammary epithelium. In Intercellular Signalling in the Mammary Gland. CJ Wilde, CH Knight, M Peaker (eds). New York: Plenum, pp 67–68.
Bradbury JM, Sykes H, Edwards PAW (1991) Induction of mouse mammary tumours in a transplantation system by sequential introduction of the myc and ras oncogenes. Int J Cancer 48:908–915.
Bradbury JM, Arno J, Edwards PAW (1993) Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB2 oncogene in reconstituted mouse mammary gland. Oncogene 8:1551–1558.
Bradbury JM, Edwards PAW, Niemeyer CC, Dale TC (1995) Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol 170:553–563.
Edwards PAW (1993) Tissue reconstitution models of breast cancer. Cancer Surv 16:79–96.
Edwards PAW, Ward JL, Bradbury JM (1988) Alteration of morphogenesis by the v-myc oncogene in transplants of mouse mammary gland. Oncogene 2:407–412.
Edwards PAW, Hiby SE, Papkoff J, Bradbury JM (1992) Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland. Oncogene 7:2041–2051.
Edwards PAW, Abram CL, Bradbury JM (1995) Genetic manipulation of mammary epithelium by transplantation. J Mammary Gland Biology and Neoplasia 1:75–90.
Edwards PAW, Abram CL, Hiby SE, Niemeyer C, Dale TC, Bradbury JM (1995) The role of erbB-family genes and Wnt genes in normal and preneoplastic mammary epithelium, studied by tissue reconstitution. In Intercellular Signalling in the Mammary Gland. CJ Wilde, CH Knight, M Peaker (eds). New York: Plenum, pp 57–66.
Aguilar-Cordova E, Strange R, Young LJT, Billy HT, Gumerlock PH, Cardiff RD (1991) Viral Ha-ras mediated mammary tumour progression. Oncogene 6:1601–1607.
Miyamoto S, Guzman RC, Shiurba RA, Firestone GL, Nandi S (1990) Transfection of activated Ha-ras protooncogenes causes mouse mammary hyperplasia. Cancer Res 50:6010–6014.
Smith GH, Gallaghan D, Zweibel JA, Freeman SM, Bassin RH, Callaghan R (1991) Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells. J Virol 65:6365–6370.
Strange R, Aguilar-Cordova E, Young LJT, Billy HT, Dandekar S, Cardiff RD (1989) Harvey-ras mediated neoplastic development in the mouse mammary gland. Oncogene 4:309–315.
Miller AD (1992) Retroviral vectors. Curr Top Microbiol Immunol 158:1–24.
DeOme KB, Faulkin LJ Jr, Bern HA, Blair PB (1959) Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19:515–520.
Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN (1991) Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors. Cancer Res 51:2642–2648.
Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN (1991) Frequent induction of mammary carcinomas following neu oncogene transfer into in situ mammary epithelial cells of susceptible and resistant rat strains. Cancer Res 51:5649–5654.
Andres AC, van der Walk MA, Schonenberger CA, Fluckiger F, LeMeur M, Gerlinger P, Groner B (1988) Ha-ras and c-myc oncogene expression interferes with morphological and functional differentiation of mammary epithelial cells in single and double transgenic mice. Genes Dev 2:1486–1495.
DanKort DL, Muller WJ (1996) Transgenic models of breast cancer metastasis. In Mammary Tumor Cell Cycle, Differentiation, and Metastasis. RB Dickson, ME Lippman (eds). Boston: Kluwer.
Webster MA, Muller WJ (1994) Mammary tumorigenesis and metastasis in transgenic mice. Semin Cancer Biol 5:69–76.
Stocklin E, Botteri F, Groner B (1993) An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice. J Cell Biol 122:199–208.
Ghattas IR, Sanes JR, Majors JE (1991) The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biol 11:5848–5859.
Friedrich G, Soriano P (1991) Promoter traps in embryonic stem cells: A genetic screen to identify and mutate developmental genes in mice. Genes Dev 5:1513–1523.
Dati C, Antoniotti S, Taverna D, Perroteau I, De Bortoli M (1990) Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells. Oncogene 5:1001–1006.
Varley JM, Walker RA (1993) The molecular pathology of human breast cancer. Cancer Surv 16:31–57.
Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115.
Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P (1989) Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57:931–936.
Siegel PM, Dankort DL, Hardy WR, Muller WJ (1994) Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumours. Mol Cell Biol 14:7068–7077.
Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55:619–625.
Lin T-P, Guzman RC, Osborn RC, Thordarson G, Nandi S (1992) Role of endocrine, autocrine and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res 52:4413–4419.
Nusse R, Varmus HE (1992) Wnt genes. Cell 69:1073–1087.
Gavin BJ, McMahon AP (1992) Differentional regulation of the Wnt gene family during pregnancy and lactation suggests a role in post natal development of the mammary gland. Mol Cell Biol 12:2418–2423.
Weber-Hall SJ, Phippard DJ, Niemeyer CC, Dale TC (1994) Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Development 57:205–214.
Bradbury JM, Niemeyer CC, Dale TC, Edwards PAW (1994) Alterations of the growth characteristics of the fibroblast cell line C3H10T1/2 by members of the Wnt gene family. Oncogene 9:2597–2603.
Parr BA, McMahon AP (1994) Wnt genes and vertebrate development. Curr Opin Genetics Dev 7:2181–2193.
Daniel CW, Silberstein GB, Van Horn K, Strickland P, Robinson S (1989) TGF-β-induced inhibition of mouse mammary ductal growth: Developmental specificity and characterization. Dev Biol 135:20–30.
Ornitz DM, Moreadith W, Leder P (1991) Binary system for regulating trangene expression in mice: Targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc Natl Acad Sci USA 88:698–702.
Sukumar S (1989) ras oncogenes in chemical carcinogenesis. Curr Top Microbiol Immunol 148:93–114.
Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K (1994) Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targetting. Science 265:103–106.
Beddington RSP, Morgernstern J, Land H, Hogan A (1989) An in situ transgenic enzyme marker for the midgestation mouse embryo and the visualization of inner cell mass clones during early organogenesis. Development 106:37–46.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Edwards, P.A.W. (1996). Tissue reconstitution, or transgenic mammary gland, technique for modeling breast cancer development. In: Dickson, R.B., Lippman, M.E. (eds) Mammary Tumor Cell Cycle, Differentiation, and Metastasis. Cancer Treatment and Research, vol 83. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1259-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1259-8_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8536-6
Online ISBN: 978-1-4613-1259-8
eBook Packages: Springer Book Archive